Most vision loss in India is preventable but often detected too late. Eye surgeon Dr K Subba Rao explains why early screening ...
Glaucoma is a leading cause of irreversible blindness because it progresses silently, often without early symptoms. Experts ...
Morning Overview on MSN
FDA clears 1st dual-action eye drop to fight age-related vision loss
Age-related near vision loss has long been treated as an inevitable annoyance of getting older, a slow erosion of clarity ...
Early safety and visual performance signals were reported at 3 months from a first-in-human (FIH) clinical study evaluating ...
Vivani Medical subsidiary Cortigent announced the results of a study evaluating its Orion visual cortical prosthesis system.
Cortigent is a leading developer of brain implant devices based on precision neurostimulation technology Cortigent is the ...
(Dr. Rita Dash) Glaucoma has a reputation as the "silent thief of sight," and for good reason. It is one of the leading ...
Moore’s widower, S. Robert Levine, MD, launched the nonprofit in his famous wife’s memory to advance research and accelerate ...
FRIDAY, Jan. 23, 2026 (HealthDay News) — Brain tumors are abnormal growths of cells in or around the brain. They can be ...
At the end of 2025, Opus Genetics completed a Type B Regenerative Medicine Advanced Therapy (RMAT) meeting with the US Food and Drug Administration (FDA) regarding OPGx-LCA5, its gene therapy ...
Cortigent is a leading developer of brain implant devices based on precision neurostimulation technology Cortigent is the only company to have obtained FDA approval of a device providing artificial ...
Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results